A Study of Envafolimab in Subjects With Stage III Non-Small Cell Lung Cancer
Clinical trial NCT05414630 · UNKNOWN
Trial details
- NCT number
- NCT05414630
- Sponsor
- Anhui Provincial Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-01
- Primary completion
- 2024-06-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.